A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective studySheri L. Spunt, Douglas S. Hawkins, Suzanne L. Wolden et al.|The Lancet Oncology|2019Cited by 182
Influence of Noncompliance With Radiation Therapy Protocol Guidelines and Operative Bed Recurrences for Children With Rhabdomyosarcoma and Microscopic Residual Disease: A Report From the Children's Oncology GroupLynn Million, Sarah S. Donaldson, James R. Anderson et al.|International Journal of Radiation Oncology*Biology*Physics|2010Cited by 47
Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early-Stage Breast Cancer in a Young Woman With Li-Fraumeni SyndromeEve Henry, Melinda L. Telli, Víctor M. Villalobos et al.|Journal of the National Comprehensive Cancer Network|2012Cited by 34
Risk-based treatment for nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients under 30 years of age: Children’s Oncology Group study ARST0332.Sheri L. Spunt, Alberto S. Pappo, Lynn Million et al.|Journal of Clinical Oncology|2014Cited by 30
Local Control For High-Grade Nonrhabdomyosarcoma Soft Tissue Sarcoma Assigned to Radiation Therapy on ARST0332: A Report From the Childrens Oncology GroupLynn Million, R. Lor Randall, Andrea Hayes‐Jordan et al.|International Journal of Radiation Oncology*Biology*Physics|2021Cited by 15